1. Home
  2. NXPL vs CPIX Comparison

NXPL vs CPIX Comparison

Compare NXPL & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • CPIX
  • Stock Information
  • Founded
  • NXPL 1997
  • CPIX 1999
  • Country
  • NXPL United States
  • CPIX United States
  • Employees
  • NXPL N/A
  • CPIX N/A
  • Industry
  • NXPL Telecommunications Equipment
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • CPIX Health Care
  • Exchange
  • NXPL Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • NXPL 32.5M
  • CPIX 35.4M
  • IPO Year
  • NXPL N/A
  • CPIX 2009
  • Fundamental
  • Price
  • NXPL $0.98
  • CPIX $4.64
  • Analyst Decision
  • NXPL
  • CPIX
  • Analyst Count
  • NXPL 0
  • CPIX 0
  • Target Price
  • NXPL N/A
  • CPIX N/A
  • AVG Volume (30 Days)
  • NXPL 130.5K
  • CPIX 4.5M
  • Earning Date
  • NXPL 11-14-2024
  • CPIX 03-04-2025
  • Dividend Yield
  • NXPL N/A
  • CPIX N/A
  • EPS Growth
  • NXPL N/A
  • CPIX N/A
  • EPS
  • NXPL N/A
  • CPIX N/A
  • Revenue
  • NXPL $66,482,000.00
  • CPIX $36,785,442.00
  • Revenue This Year
  • NXPL N/A
  • CPIX N/A
  • Revenue Next Year
  • NXPL N/A
  • CPIX N/A
  • P/E Ratio
  • NXPL N/A
  • CPIX N/A
  • Revenue Growth
  • NXPL 179.89
  • CPIX N/A
  • 52 Week Low
  • NXPL $0.71
  • CPIX $1.04
  • 52 Week High
  • NXPL $2.68
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 45.18
  • CPIX 83.81
  • Support Level
  • NXPL $0.98
  • CPIX $2.08
  • Resistance Level
  • NXPL $1.08
  • CPIX $6.43
  • Average True Range (ATR)
  • NXPL 0.10
  • CPIX 0.53
  • MACD
  • NXPL -0.02
  • CPIX 0.27
  • Stochastic Oscillator
  • NXPL 18.75
  • CPIX 74.94

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: